ATM and neoplasm: Mechanistically, RUNX3 recruits phosphorylated forms of ATM onto p53 and induces ATM-dependent phosphorylation of p53 at Ser-15 after DNA damage, suggesting that RUNX3 acts as a co-activator for tumor-suppressive p53 (Figure 4A).